This inventor holds 1 USPTO granted patent. Top assignee: The Institute of Cancer Research. Active years: 1990.
Company Filing History:
Years Active: 1990
Title: Richard Tedder: Innovator in Retroviral Diagnostics
Introduction
Richard Tedder is a prominent inventor based in London, GB. He has made significant contributions to the field of retroviral diagnostics, particularly in the detection of antibodies related to retroviruses such as the AIDS virus. His innovative approach has paved the way for improved diagnostic methods in medical science.
Latest Patents
Richard Tedder holds a patent titled "Viral isolates and their use in diagnosis." This patent describes a method for assaying samples, such as transfusion blood, for antibodies to retroviruses. The process involves using an insolubilized antigen that comprises retrovirus antigens bound to globulin, which is then attached to an inert solid support. An immunoglobulin containing specific antibodies to the retrovirus antigens is labeled with a revealing label. The soluble phase is separated from the insoluble phase, allowing for the determination of the quantity of the revealing label associated with either phase. This method enhances the identification of antibody-containing specimens, particularly for retroviruses like human T-lymphotropic retrovirus HTLV-I, II, or III, and a new retrovirus isolate CBL-1 related to AIDS.
Career Highlights
Richard Tedder is affiliated with The Institute of Cancer Research, where he continues to work on advancing diagnostic techniques. His research has been instrumental in improving the accuracy and efficiency of retroviral testing, which is crucial for public health.
Collaborations
Throughout his career, Richard has collaborated with notable colleagues, including Robin Weiss and Rachanee Cheingsong-Popov. These partnerships have contributed to the development of innovative solutions in the field of retroviral diagnostics.
Conclusion
Richard Tedder's work in retroviral diagnostics exemplifies the impact of innovation in medical science. His patent and ongoing research efforts continue to enhance the understanding and detection of retroviruses, ultimately benefiting public health and patient care.